Financial results - ENDEMEDICA SRL

Financial Summary - Endemedica Srl
Unique identification code: 29892390
Registration number: J23/605/2012
Nace: 8621
Sales - Ron
297.015
Net Profit - Ron
51.588
Employee
6
The most important financial indicators for the company Endemedica Srl - Unique Identification Number 29892390: sales in 2023 was 297.015 euro, registering a net profit of 51.588 euro and having an average number of 6 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala generala having the NACE code 8621.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Endemedica Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 79.839 111.778 124.664 127.070 148.590 170.405 207.495 248.209 341.942 297.015
Total Income - EUR 80.248 111.780 124.664 127.464 148.590 170.405 207.909 249.015 345.041 299.815
Total Expenses - EUR 68.248 107.174 125.406 139.291 106.274 142.831 152.065 206.415 245.567 245.952
Gross Profit/Loss - EUR 12.000 4.606 -742 -11.827 42.316 27.574 55.844 42.599 99.474 53.863
Net Profit/Loss - EUR 10.190 3.296 -822 -17.977 40.909 25.870 53.873 40.278 96.992 51.588
Employees 6 8 10 9 7 7 7 7 7 6
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -12.9%, from 341.942 euro in the year 2022, to 297.015 euro in 2023. The Net Profit decreased by -45.109 euro, from 96.992 euro in 2022, to 51.588 in the last year.

Check the financial reports for the company - Endemedica Srl

Rating financiar

Financial Rating -
Endemedica Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Endemedica Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Endemedica Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Endemedica Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Endemedica Srl - CUI 29892390

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 18.274 17.389 15.486 11.745 24.191 24.668 13.293 9.645 37.007 29.098
Current Assets 29.468 30.359 44.033 22.894 68.697 53.140 88.603 84.570 104.707 70.183
Inventories 1.368 3.480 0 0 0 0 0 0 0 0
Receivables 3.295 9.452 18.507 14.716 36.270 33.924 65.690 18.970 85.308 60.115
Cash 24.804 17.427 25.527 8.178 32.427 19.216 22.912 65.601 19.400 10.069
Shareholders Funds 9.278 12.651 -778 -18.959 25.902 25.919 53.921 40.325 97.048 51.644
Social Capital 45 45 45 44 45 48 48 46 47 46
Debts 40.438 35.097 60.297 53.598 66.986 52.017 47.975 53.891 44.667 48.800
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8621 - 8621"
CAEN Financial Year 8621
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 70.183 euro in 2023 which includes Inventories of 0 euro, Receivables of 60.115 euro and cash availability of 10.069 euro.
The company's Equity was valued at 51.644 euro, while total Liabilities amounted to 48.800 euro. Equity decreased by -45.109 euro, from 97.048 euro in 2022, to 51.644 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Endemedica Srl

Comments - Endemedica Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.